hi CD69 hi cells, thereby affording more stable T follicular helper (Tfh)-GC B cell contacts. These data support a model whereby commitment to the plasma cell begins in the GC and suggest that stability of Tfh-GC B cell contacts is key for plasma cell-prone GC cell formation.
Correspondence kurosaki@ifrec. osaka-u.ac.jp In Brief Ise et al. identify the plasma cell-prone LZ GC B cells whose generation relies on the amount of CD40 signal. Higher expression of ICAM-1 and SLAM in those cells facilitates more stable contacts with Tfh cells, suggesting that strength of Tfh-GC B cell interaction critically regulates formation of plasma cell precursors.
INTRODUCTION
Affinity maturation of B cells in the germinal center (GC) is a process of evolution involving mutation of B cell receptors (BCRs) followed by selection through antigens and T cells . Consequently, an important GC function is to make the most effective antibodies possible, thereby providing efficient immune protection.
GCs are tightly confined clusters of cells within the follicle, in which GC B cells highly express the transcription factor Bcl6 and the G-protein-coupled receptor sphingosine-1-phosphate receptor (S1pr2) that promotes their retention within the GC structure (Green et al., 2011; Huang and Melnick, 2015) . In GCs, B cells migrate between two zones, the light zone (LZ) and the dark zone (DZ), and in the latter, they proliferate and hypermutate their BCRs . In the LZ, antigenpresenting follicular dendritic cells and T follicular helper (Tfh) cells reside, and here, GC B cells expressing newly mutated BCRs capture antigen and internalize it for presentation to T cells (De Silva and Klein, 2015) . Subsequently, antigen-and T cell-dependent selection occurs, whereby positively selected GC B cells have the ''choice'' of recycling to the DZ for further mutation or exiting the GC as memory cells or plasmablasts Suan et al., 2017) .
For plasma cell differentiation, BCRs in post-GC plasma cells are heavily dominated with a high-affinity mutation, even at a time point when this mutation is present in only a small fraction of GC cells (Phan et al., 2006) . Hence, higher-affinity cells are directed to the plasma cell fate, whereas lower-affinity cells enter into the recycling GC cell pool.
In regard to the selection mechanism, it has been postulated that precursor cells (selected toward recycling GC or plasma cell fates) become committed already in the GCs Victora and Nussenzweig, 2012) , thereafter entering the recycling DZ or plasmablast pool, respectively. Indeed, it has been suggested that a small fraction of LZ GC cells expressing c-Myc, a key cell-cycle regulator, correspond to such precursor cells; c-Myc + cells are enriched for high-affinity BCRs, and ablation of Myc affects DZ reentry (Calado et al., 2012; Dominguez-Sola et al., 2012) . But, assuming that distinctive precursors for GC recycling or plasma cell fates exist, it is unclear whether both precursors or only GC recycling precursors express c-Myc. It was also reported that IRF4, a key factor for initiating plasma cell differentiation, is expressed in a small subset of mouse LZ GC B cells (De Silva et al., 2016) . However, the published data show that these IRF4 + cells do not express Bcl6. Considering the recent evidence that early plasmablasts reside in the GC LZ region (Kr€ autler et al., 2017) , the observed IRF4 + cells are more likely early plasmablasts rather than bona fide GC B cells. Thus, the model of precursors in the GC for fate decisions still remains speculative.
Here, to test this model and, if correct, to address how such precursor GC cells are formed, we first identified a small LZ GC cell population (Bcl6 lo CD69 hi ) with higher-affinity BCRs that expresses IRF4 and favors the plasma cell fate over GC recycling. In contrast, Bcl6 hi CD69
hi LZ GC cells with lower-affinity favored GC recycling, The Bcl6 lo CD69
hi population has begun to downregulate Bcl6 and S1pr2 and to upregulate Gpr183, which likely represents the process of restraining the GC program and of exiting the GC. Mechanistically, Bcl6 lo CD69 hi cell formation relied on CD40 in a dose-dependent manner. Furthermore, we found that expression of intercellular adhesion molecule 1 (ICAM-1) and signaling lymphocytic activation molecule (SLAM) in LZ GC cells was upregulated by CD40 stimulation. Consequently, Bcl6 lo CD69 hi cells expressed these adhesion molecules higher than Bcl6 hi CD69 hi cells, thereby affording more stable GC B-Tfh cell contacts; attenuating this interaction decreased expression of IRF4. Thus, we propose a precursor model in which the duration of Tfh-GC B cell interactions is a key decisive factor for formation of plasma cell precursor versus GC recycling precursor cells.
RESULTS

GC LZ B Cell Subsets Can Be Identified Using a Bcl6
Reporter Based on the requirement for IRF4 in post-GC plasma cell differentiation (De Silva et al., 2012) , we hypothesized that IRF4 + LZ GC cells might exist as plasma cell precursors. Since Irf4 reporter mice are currently not available, in order to circumvent this limitation, we used Bcl6 reporter mice as an alternative. We reasoned that a Bcl6 low LZ GC B cell subset might exist and could contain the IRF4 + cells, because previous experiments using transformed GC B cell lines show downregulation of Bcl6 by IRF4 overexpression (Saito et al., 2007) . We immunized Bcl6 reporter mice with 4-hydroxy-3-nitrophenylacetyl (NP)-CGG (chicken g-globulin) in CFA (complete Freund's adjuvant) and analyzed NP-specific GC B cells and plasmablasts at day 12. In our immunization protocols, more than 80% of NP + plasmablasts generated at day 12 were derived from GCs, assessed using S1pr2ERT2Cre-tdTomato fate-mapping mice ( Figure S1A ). S1pr2 is specifically expressed in GC cells, thereby expressing tdTomato in GC B cells at the time of tamoxifen treatment and in the resulting progeny cells, including post-GC plasmablasts (Shinnakasu et al., 2016) . As expected, mRNA expression of Bcl6 and S1pr2 was lower and mRNA expression of Gpr183 was higher in Bcl6 lo LZ GC cells than in Bcl6 hi LZ cells (Figures S1B and S1C), implying that they are a cell population in the process of exiting the GC. To rule out the possibility that these Bcl6 lo LZ cells were cells that had just recently joined the GC reaction at day 12, we stained for Ki67, because the newly joining cells showed higher Ki67 expression ( Figure S1D ). The Bcl6 lo LZ cells had relatively low Ki67 expression compared to pre-GC B cells at day 5 after immunization. The Bcl6 lo LZ fraction consisted of IRF4 + and IRF4 À populations ( Figure 1A ). After testing several surface molecules, we found that CD69 was a good marker to distinguish these two populations. CD69 is rapidly induced by BCR or CD40 stimulation and, more importantly, is highly expressed in positively selected LZ GC B cells (Calado et al., 2012 Alternatively, this fraction might contain dying cells that were not positively selected (Mayer et al., 2017 Figure 1B ). An IRF4 + population was also detected in Bcl6 lo DZ B cells ( Figure S1E ). Since the expression of IRF4 was high and equivalent to those in plasmablasts, this IRF4 + DZ population was likely to be Blimp-1 + early plasma cells (Kr€ autler et al., 2017) . During the course of the GC response, overall, there were no dramatic changes in the proportions of Fraction 1 and Fraction 2 cells ( Figure 1C ). When we used B cells harboring a transgenic NP BCR (B1-8 hi ) (Shih et al., 2002) instead of the non-BCR transgenic B cells described above, these NP-specific GC B cells had similar proportions of each Fraction ( Figure S1F ). (Allen et al., 1988) . The obtained sequences were assessed by CDR3 sequence as well as frequency and distribution of somatic hypermutation, and ''clonal distance'' was determined. As shown in Figure 2A Figure 2B ). To further characterize each subset, we performed gene expression analysis at day 12 using barcode-based digital RNA sequencing (RNA-seq) (Shiroguchi et al., 2012 Figure S2A ). We further analyzed the expression of genes that have been reported to be relevant to GC B cell biology ( Figure 2D Figure S2B ). We conducted a further gene set enrichment analysis (GSEA) overlaying gene signatures of GC B cells (Gloury et al., 2016) . This analysis showed that the GC signature genes were significantly downregulated in Although PCA showed no significant overall association between Bcl6 lo CD69 hi (Fraction 1) and GC-derived plasmablasts ( Figure 2C ), IRF4 target genes that are highly expressed in plasma cells (Shaffer et al., 2008) To further assess the relationship between Bcl6 lo CD69 hi (Fraction 1) cells and plasma cell fate, we attempted to transfer this subset into immunized mice; but, despite several efforts, we could not. Hence, we adopted an opposite strategy: we examined whether dysfunction or depletion of Fraction 1 cells abolished only the plasma cell fate. For this, we used an inducible Irf4 deletion in GC B cells; Irf4 f/À S1pr2ERT2cre-tdTomato B1-8 hi B cells were transferred into congenically marked mice and immunized, and deletion of Irf4 was induced by tamoxifen treatment ( Figure S3A ). At the floxed Irf4 allele, successful deletion can be monitored by expression of eGFP, thereby allowing us to distinguish Irf4 +/À and Irf4 À/À cells by eGFP expression (Klein et al., 2006) . Tamoxifen Figure S4A ). For this, we adoptively co-transferred two types of allotypically distinguishable B cells harboring Cd40 +/+ S1pr2ERT2cre-tdTomato B1-8 hi and Cd40 f/+ S1pr2ERT2cre-tdTomato B1-8 hi into congenically marked mice, then assessed their fates during GC responses ( Figure 3B ). We confirmed that, in this co-transfer experiment, also not decreased at a later time point ( Figure S4C ). In contrast, the numbers of plasmablasts derived from Cd40 +/À B1-8 hi B
Bcl6
cells were significantly lower ( Figure 3D ). Furthermore, the numbers of Bcl6 lo CD69 hi (Fraction 1), but not Bcl6 hi CD69 hi (Fraction 2), cells derived from Cd40 +/À B1-8 hi B cells were about 2-fold reduced ( Figure 3F ). Thus, we conclude that CD40 expression in a dose-dependent manner affects formation of Bcl6 lo CD69
hi (Fraction 1) cells, which in turn, influences generation of the resultant plasmablasts.
Although the numbers of GC cells were not apparently affected by CD40 haploinsufficiency, the requirement for CD40 in GC maintenance is clear. Indeed, when we used an inducible complete deletion of Cd40 ( Figures S5A and S5B ), both GC and plasmablast populations collapsed ( Figure S5C ). Moreover, both Fraction 1 and Fraction 2 cells were dramatically decreased ( Figure S5D ). Given that signatures of CD40 signals are more highly imprinted in Bcl6 Another important component of T cell help is a cytokine; IL-21 predominantly activates Stat3 and regulates B cell differentiation (Spolski and Leonard, 2008) . Here, we examined the effect of haploinsufficiency of Stat3 on GC and plasma cell fates (Figure 4) . In the case of Stat3 haploinsufficiency, about a 45% decrease could be achieved, assessed by qPCR ( Figure 4A ). Similar to the case with Cd40 haploinsufficiency, the numbers of GC cells derived from Stat3 f/+ B1-8 hi B cells were unaffected, whereas the numbers of the resultant plasmablasts were significantly decreased, compared with those derived from Stat3 Figure 4B ). Nevertheless, the development of 
IRF4 Mediates Repression of Bcl6 and S1pr2 and Induction of Gpr183
Considering that Bcl6 mediates GC confinement by downregulation of Gpr183 (Huang et al., 2014) , repression of Bcl6 by IRF4 (Saito et al., 2007) could provide a potential explanation for why the plasma cell-prone Fraction 1 cells are in the process of restraining the GC recycling fate and exiting the GC. To test whether IRF4 expression could cause such consequences, we examined the effects of Irf4 haploinsufficiency on expression of Bcl6, S1pr2, and Bcl6 target, Gpr183 (Huang et al., 2014 hi (Fraction 1) cells acquire high T cell help, we focused on Tfh-GC B cell interactions. In this regard, we found that, among integrin ligand and SLAM family members on non-BCR transgenic GC B cells ( Figure S2E ), cell-surface expression of ICAM-1 (CD54) and SLAM (CD150) was significantly higher in Bcl6 lo CD69 hi (Fraction 1) cells than in Bcl6 hi CD69 hi (Fraction 2) cells; in addition, CD40 expression was augmented in this plasma cell-prone fraction ( Figure 5A ). Consistent with these results, we also demonstrated higher expression of CD40, ICAM-1, and SLAM in the high-affinity NP + IgG1 + LZ GC B cells than in the low-affinity ones ( Figure 5B ). These data raised the possibility that, depending on the initial signal strength through T cell help and/or BCR signaling, an individual GC B cell forms either a transient or sustained T-B conjugate, thereby acquiring the differential T cell help required for subsequent fate decisions.
To test this possibility, we first examined the Tfh-GC B cell interaction status by employing a flow-cytometry-based in vitro assay on unfixed conjugates between ovalbumin (OVA)-specific T cell receptor transgenic (OT-II) Tfh cells and OVA323-339-pulsed B1-8 hi GC B cells. Each fraction of B1-8 hi LZ GC B cells was prepared from NP-CGG-immunized mice transferred with B1-8 hi B cells, while OT-II Tfh cells were prepared from OVA-immunized mice transferred with OT-II T cells ( Figure 5C ). An OVA-peptide dose-dependent increase in Tfh-GC B cell conjugates was observed, and these conjugates were most efficiently formed by Figure 6B ). Thus, more T cell help promotes increased expression of ICAM-1, SLAM, and Cd40, and this leads to formation of more stable Tfh-GC B cell conjugates, typically seen in the Bcl6 lo CD69 hi (Fraction 1) LZ GC cells (Figures 5D and 5E) .
To determine the importance of stable Tfh-GC B cell conjugates, we added anti-ICAM-1 Ab (antibody) to the above in vitro conjugate system (OT-II Tfh cells and OVA323-pulsed B1-8 hi GC B cells). Treatment of anti-ICAM-1, but not control Ab, inhibited both Tfh-GC B cell conjugate formation and IRF4 expression ( Figure 6C ), suggesting that stable Tfh-GC B cell interaction contributes to induction of IRF4 expression. Consequently, in vivo anti-ICAM-1 Ab treatment more severely affected the numbers of Bcl6 lo CD69 hi (Fraction 1) cells (expressing IRF4) than Bcl6 hi CD69 hi (Fraction 2) cells ( Figure 6D ). In addition, expression of Irf4 mRNA was decreased in CD69 hi cells by anti-ICAM-1 treatment ( Figure 6D ). Together, we conclude that stable interaction between Tfh and GC B cells is required for generation of plasma cell-prone GC B cells.
DISCUSSION
It has been thought that commitment to the plasma cell fate begins while B cells are still in the GC Victora and Nussenzweig, 2012) , but the main obstacle to test this model and, if correct, to clarify how the plasma cell-prone GC cells *p < 0.05; **p < 0.01; ***p < 0.005; n.s., non-significant; unpaired Student's t test. Bars indicate mean ± SD. All data are from at least two independent experiments (A, B, and D, n = 3; E, n = 4). Please also see Figure S2 .
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Anti-ICAM-1 (300 μg) originally proposed, the asymmetric model for post-GC fate decisions seems not to operate in our experimental settings. Apart from T cell help, the requirement for BCR signaling in GC fate decisions has been investigated (Kr€ autler et al., 2017) . It has become clear that signals provided by the BCR and T cell help interact and participate in the plasma cell fate decision during GC reactions. Among the various components of Tfh cell help, the role of CD40 in recycling GC versus plasma cell fates has been controversial. Previous experiments using direct stimulation of CD40 or loading of GC B cells with extrinsic peptides led to different conclusions. Although both approaches lead to a dramatic increase in post-GC plasma cell fate, direct stimulation of CD40 (Erickson et al., 2002; Kishi et al., 2010) , but not stimulation with extrinsic peptide , curtailed the GC reaction. Our finding that decision between plasma cell and GC recycling fates is dependent on CD40 in a dose-dependent manner could reconcile these previous observations. In contrast to strong supra-physiological and monotonous CD40 signaling, which generates only plasmablasts, stimulation by extrinsic peptide could generate a broader range of T cell help. Indeed, the extent of GC proliferation in these extrinsic peptide experiments could be altered, depending upon the dose of the injected peptide ; therefore, these GC B cells could take both plasma cell and GC recycling fates. Our genetic evidence for the CD40 requirement in post-GC plasma cell differentiation seems to be inconsistent with results from a recent study demonstrating apparently normal generation of early plasma cells after anti-CD40L blocking in hen egg lysozyme (HEL)-conjugated sheep-red blood cell (RBC)-immunized mice (Kr€ autler et al., 2017) . Given that viruslike particle immunization induces GC B cells as well as IgG + memory B cells independently of T cell help to some extent (Liao et al., 2017) , one straightforward interpretation is that the sheep RBC immunization model induces plasma cell responses with a less stringent T cell requirement.
BCR affinity serves as a determinant of the amount of peptide-MHC II (pMHC) presented on the GC cell surface; GC B cells with higher pMHC densities compete favorably for access to Tfh cells . Also, this more intense pMHC interaction induces inside-out signaling by cognate Tfh cells to activate integrins (Burbach et al., 2007) as well as to externalize CD40L from intracellular stores, making it more available for cognate GC B cells (Liu et al., 2015) . As a potential mechanism connecting CD40 signal strength, GC B-Tfh cell contact, and post-GC plasma cell fates, we propose a model based on the following three lines of evidence, in which strong CD40 signaling facilitates stable GC B-Tfh cell interactions, thereby contributing to development of Bcl6 Two-photon microscopy experiments demonstrated that most contacts between GC B and Tfh cells are of short duration (about 2 min), and only about 4% of these contacts lead to the formation of stable conjugates (5 to 60 min) (Allen et al., 2007) . Similarly, during extrinsic peptide stimulation, some rare GC B cells were reported to interact with Tfh cells for more than 20 min . Thus, we speculate that these GC B cells forming long-lived contacts correspond to the small LZ Bcl6 lo CD69 hi GC population shown here. Within the GC, GC B cells also interact with follicular dendritic cells (FDCs), although the association time is brief, on the order of a second (Nowosad et al., 2016) . Thus, our in vivo anti-ICAM-1 blocking data do not exclude the possible involvement of ICAM-1 in FDCs in suppressing the development of Bcl6 lo CD69 hi cells. *p < 0.05; **p < 0.01; ***p < 0.005; n.s., non-significant; unpaired Student's t test. Bars indicate mean ± SD. All data are from at least two independent experiments (A-C, n = 3; D, n = 4). Please also see Figure S2 .
Assuming that plasma cell-prone GC cells form long-lived contacts with Tfh cells, how do these cells begin to egress from the GC? Because these cells are in the process of upregulating Gpr183, one possibility is that Gpr183 ligand-mediated chemotaxis might allow them to release from their interaction with Tfh cells and move away from the GC. Indeed, Gpr183 overexpression was reported to be sufficient to promote B cell localization to the outer follicle (Gatto et al., 2009; Pereira et al., 2009 ). In addition, decreased GC confinement through downregulation of S1pr2 might also contribute to the GC egress. Another possibility is that, during the transition from GC B cells to plasmablasts, cellular locomotion machinery could be reorganized, thereby contributing to such migration. In fact, B cells and plasma cells are known to utilize distinct migration mechanisms .
In (Nahar et al., 2011) . Thus, it is possible that IRF4-mediated downregulation of Bcl6 may change the expression pattern of cell-cycle regulators, and this may lead to such less proliferation status. As a non-exclusive possibility, the epigenetic modifications such as DNA hypomethylation (Barwick et al., 2016) hi plasma cell-prone GC cells barely express Blimp-1, given the previous evidence that IL-21-mediated Stat3, together with IRF4, activates Blimp-1 (Kwon et al., 2009) . Because Prdm1 locus is hypo-methylated in plasmablasts relative to naive B cells (Barwick et al., 2016) , one possibility is that Stat3 and IRF4 are required, but not sufficient, for inducing Blimp-1. Additional epigenetic changes after the Bcl6 lo CD69
hi stage might be required. Another possibility is that the Bcl6 lo CD69 hi GC B cells still express Bcl6, Pax5, and Bach2, which, in turn, repress Blimp-1 (Nutt et al., 2015) . In this case, downregulation of these repressive transcription factors is required for Stat3 to actively participate in Blimp-1 expression together with IRF4 (Kwon et al., 2009) . Hence, we would propose that another checkpoint layer for post-GC plasma cell fate decisions exists between plasma cell-prone GC and plasmablast stages. Once Blimp-1 is expressed, a feed-forward loop is formed by which Blimp-1 acts to increase IRF4 expression, thereby stabilizing the plasmablast phenotype (Minnich et al., 2016) .
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice B1-8 hi mice (Shih et al., 2002) , Bcl6-YFP reporter mice (Kitano et al., 2011) , S1pr2-ERT2cre mice (Shinnakasu et al., 2016) , Stat3 f/f mice (Takeda et al., 1998) , and Irf4 À/À mice (Mittr€ ucker et al., 1997) are described elsewhere. Ai-14 mice, Irf4 f/f mice, and OT-II mice were purchased from The Jackson Laboratory. C57BL/6 mice were purchased from CLEA Japan. Cd40 f/f mice were generated by homologous recombination using Bruce 4 ES cells so that exons 7, 8, and 9 were flanked with two loxp sites ( Figure S3A ). All mice were bred and maintained under specific pathogen-free conditions and all animal experiments were performed under the institutional guidelines of Osaka University.
METHOD DETAILS
Immunization, treatments, and adoptive transfer Mice were immunized subcutaneously with 25 mg of NP-CGG in CFA. Deletion of the loxP-flanked allele of the target genes was induced by oral administration (p.o.) of 2 mg tamoxifen (Sigma-Aldrich) in sunflower oil once per day for 3 days. For anti-ICAM-1 treatment, the mice were immunized with NP-CGG in CFA on day 0 and were injected i.p. with 300 mg of anti-ICAM-1 (YN/1.7.4; Bio X Cell) or control rat IgG2b (LTF-2; Bio X Cell) on day 10 and 11. Adoptive transfer of B1-8 hi B cells was performed as described previously (Shinnakasu et al., 2016) . In brief, splenic B cells were purified by magnetic depletion using CD43 microbeads and an AutoMACS system (Miltenyi Biotec). Purified B1-8 hi B cells containing 1x10 5 NP-binders (a 1:1 mixture of 5 3 10 4 NP-binders for co-transfer experiments) were transferred i.v. into recipient mice. For preparation of OVA-specific Tfh cells, CD4 + T cells were purified from spleen of OT-II mice using CD4 microbeads (Miltenyi Biotec) and 1x10 6 CD4 + T cells were injected i.v. into recipient mice, followed by immunization with 25 mg of OVA in CFA.
Flow Cytometry and Cell sorting
Single cell suspensions of draining lymph node cells were prepared in PBS containing 1% BSA and 2 mM EDTA, stained with Abs, and analyzed on a FACSCanto II (BD Biosciences). Anti-B220 (RA3-6B2), IgG1 (A85-1), CD45.2 (104), CXCR5 (2G8), and PD1 (J43) were purchased from BD biosciences. Anti-CD16/32 (93), GL7 (GL7), CXCR4 (2B11), CD69 (H1.2F3), and CD4 (GK1.5) were purchased from Thermo Fisher Scientific. Anti-CD38 (90), CD86 (GL-1), CD138 (28102), CD44 (IM7), CD45.1 (A20), CD40 (3/23), ICAM-1 (YN1/1.74), SLAM (TC15-12F12.2), and Va2 (B20.1) were purchased from BioLegend. APC-conjugated NP was prepared as described previously (Shinnakasu et al., 2016) . For intracellular staining, the cells were fixed and permeabilized using a Foxp3 staining kit (Thermo Fisher Scientific) for anti-IRF4 (3E4; Thermo Fisher Scientific), anti-Bcl6 (K112-91; BD bioscience), or antiKi67 (16A8, BioLegend) staining. For EdU incorporation assays, mice were injected i.v. with 1 mg EdU (Thermo Fisher Scientific) in PBS 30 min before sacrifice. Lymph node cells were surface-stained, and then EdU-incorporation was detected using a Click-iT Plus EdU Flow Cytometry Assay kit (Thermo Fisher Scientific) according to the manufacturer's instructions. For detection of EdU incorporation by IRF4-deleted GFP + B cells, GFP + or GFP À B cells were sorted before detection of EdU, because GFP expression is lost by the fixation and permeabilization, BCR sequencing analysis NP-specific IgG1 + GC B cells and plasmablasts in the draining lymph nodes of the Bcl6-YFP reporter mice immunized 12 days before were single cell sorted into 10 mL of RNase-free water containing 50 ng carrier RNA using a FACSaria II (BD Biosciences). cDNA was synthesized and V H 186.2-Cg1 sequences were analyzed as described previously (Kaji et al., 2012) . For the analysis of clonal similarity between the cell type, IgBLAST was utilized for the VDJ gene assignments and extraction of the CDR3 region of each sequence. Since V H 186.2-Cg1 sequences were analyzed, the lineage assignment was done solely based on the similarity of the CDR3 DNA sequences. To determine the lineage threshold of CDR3 distances, the maximum number of mutations on the V-gene regions of each pair was calculated and the number was adopted to the aligned CDR3s by MAFFT (data not shown). Finally, the number of sequence neighbors of either plasmablasts or DZ cells on the non-redundant set was calculated within the lineage. The sequences were aligned by MAFFT and the pairwise distance of the sequences was utilized as the measure to distinguish neighbors from non-neighbors.
Digital RNA-seq and data analysis B cells from B1-8 hi Bcl6-YFP reporter mice (CD45.1 + ) or from B1-8 hi S1pr2-ERTcre Ai14 mice (CD45.1 + ) were transferred to C57BL/6 mice, followed by immunization with NP-CGG in CFA. The mice transferred with B1-8 hi S1pr2-ERT2cre Ai14 B cells were treated with tamoxifen on day 6, 7, and 8. On day 12, 100 GC B cells or 100 GC-derived plasmablasts from the draining lymph nodes were sorted into a tube using a FACSaria II (BD Biosciences). Digital RNA-sequencing was performed as described previously (Tenno et al., 2017) . Differential gene expression was determined from the digital RNA seq data using DESeq2. To identify genes differentially expressed among GC B cell fractions, log 2 fold changes and false discovery rates were calculated between Bcl6 lo CD69 hi (Fraction 1) and Bcl6 hi CD69 hi (Fraction 2) cells. Genes were considered differentially expressed when they had log 2 fold changes of > 1.5 or < 1.5, false discovery rates of < 0.01, and p value of < 0.001. Gene set enrichment analysis (GSEA) was performed with software from the Broad Institute (Subramanian et al., 2005) . The lists of gene signatures of genes upregulated by CD40 or BCR stimulation (Shinnakasu et al., 2016; Victora et al., 2010) , or gene signatures of GC B cells (Gloury et al., 2016) , or plasma cell-related IRF4 target genes (Shaffer et al., 2008) have been described previously.
Real-time PCR
Total RNA was prepared with RNeasy micro kit (QIAGEN) and was transcribed with ReverTra Ace qPCR Master Mix (TOYOBO). Realtime qPCR was performed as described previously (Ise et al., 2014) with Power SYBR Green PCR Master Mix (Applied Biosystems). Expression of Actb mRNA were used for normalization. The following primers were used for qPCR analysis: Prdm1 forward, In vitro culture Sorted LZ GC B cells (5000-10,000 cells) were cultured in 96-well U-bottom plates with recombinant mouse CD40 ligand (100 ng/ml, R&D Systems) or recombinant mouse IL-21 (10 ng/ml, R&D Systems) for 5 h. For the analysis of antigen-induced GC B cell responses, sorted LZ GC B cells (5000-10,000 cells) or LZ Fraction 1-3 cells (2000-5000 cells) were plated into 96-well V-bottom plate and then incubated with 1 or 10 mM OVA323-339 for 2 h at 37 C. Sorted CXCR5 + OT-II CD4 + T cells (10,000 cells) were added to each well and centrifuged briefly. In the conjugate formation assay, GC B cells and OT-II T cells were incubated for 30-60 min at 37 C. Cells were vigorously pipette to disrupt nonspecific conjugates and CD4 expression on B220 + cells was analyzed on a FACSCanto II (BD Biosciences). For the measurement of IRF4 expression, GC B cells and OT-II T cells were incubated for 5 h at 37 C and intracellular IRF4 expression was analyzed as described above. In the ICAM-1 blocking experiment, OVA323-339-pulsed GC B cells were incubated with 100 mg/ml of anti-ICAM-1 mAb or isotype control Ab for 30 min and washed before OT-II T cells were added.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed with a two-tailed unpaired Student's t test, a two-tailed paired Student's t test, or a Fisher's exact test using Graphpad Prism software. P values < 0.05 were considered significant (*p < 0.05, **p < 0.01, ***p < 0.005, ****p < 0.001), p R 0.05 not significant (n.s.). Error bars denote ± SD.
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